NCT00516035 Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults Status COMPLETED Phase PHASE1
NCT00514709 Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants Status COMPLETED Phase PHASE3
NCT00510874 Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults Status COMPLETED Phase PHASE1
NCT00506350 Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults Status COMPLETED Phase PHASE2
NCT00505453 A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine Status COMPLETED Phase PHASE3
NCT00502593 Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children Status COMPLETED Phase PHASE2
NCT00492063 Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly Status COMPLETED Phase PHASE3
NCT00491985 Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children Status COMPLETED Phase PHASE2
NCT00491257 A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine Status COMPLETED Phase PHASE2
NCT00490633 Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission Status COMPLETED Phase NA
NCT00488046 Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults Status COMPLETED Phase PHASE1
NCT00486980 Intramuscular Peramivir for the Treatment of Uncomplicated Influenza Status WITHDRAWN Phase PHASE3
NCT00479648 A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants Status COMPLETED Phase PHASE2
NCT00476307 Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above Status COMPLETED Phase PHASE3
NCT00464672 Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old Status COMPLETED Phase PHASE3
NCT00462215 Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) Status COMPLETED Phase PHASE3
NCT00453999 Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza Status COMPLETED Phase PHASE2